Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

7,150 results found

Use advanced search filters to refine your search

2 filters applied

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Article

    French Agency Issues Control Banding Protocol For Nano Risk

    In response to possible risks from exposure to nanoparticles, Anses, the French Agency for Food, Environment, Health and Occupational Safety, has developed a protocol based on control banding.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Day Pitney LLP
    Day Pitney LLP
  • Article

    FTC Opens New Investigations Of "Pay-For-Delay" Generic Drug Deals

    FTC has opened new investigations into agreements between brand-name and generic drug manufacturers that purportedly delay consumer access to generic drugs.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Jones Day
    Jones Day
Article

Full Energy And Commerce Committee Approves Three Bipartisan Health Bills

On June 10, 2014, the full House Energy and Commerce Committee approved by voice vote three bipartisan public health bills.
United StatesFood, Drugs, Healthcare, Life Sciences
Reed Smith
Reed Smith
  • Article

    Future-Proofing In-House Counsel: The Top Five Skills You Need Now

    Partner Jason Schultz explores the evolving role of in-house counsel in healthcare organizations, identifying five critical capabilities that legal professionals must develop to remain effective strategic partners. The article examines how modern healthcare lawyers can enhance their value by mastering skills beyond traditional legal expertise, including project management, emotional intelligence, and business acumen.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Barnes & Thornburg LLP
    Barnes & Thornburg LLP
  • Article

    Genentech Voluntarily Recalls SUSVIMO (Ranibizumab)

    This month, Genentech announced a voluntary recall of the ranibizumab injection (SUSVIMO) ocular implant and associated insertion tool. SUSVIMO, which provides continuous administration of the anti-VEGF...
    United StatesFood, Drugs, Healthcare, Life Sciences
    Goodwin Procter LLP
    Goodwin Procter LLP
  • Podcast

    Highlights For Research Institutions And Sponsors In FDA's Recent Draft Guidance On Decentralized Clinical Trials (Podcast)

    In this episode, Michael Hinckle and Rebecca Schaefer provide an overview of FDA's recently issued draft guidance on decentralized clinical trials.
    United StatesFood, Drugs, Healthcare, Life Sciences
    K&L Gates
    K&L Gates
  • Podcast

    HIPAA Modernization: HHS's Proposed Privacy And Security Rule Updates (Podcast)

    The Department of Health and Human Services has proposed significant updates to both the HIPAA Security Rule and Privacy Rule, marking the first major overhaul in years. These proposed rulemakings introduce key policy changes that will impact healthcare organizations, business associates, and covered entities across the industry. Understanding the rationale behind these modifications and their potential implementation timeline is crucial for stakeholders preparing for compliance.
    United StatesFood, Drugs, Healthcare, Life Sciences
    K&L Gates
    K&L Gates
  • Podcast

    In House Warrior With Daniel Kracov (Podcast)

    In this podcast, Daniel Kracov joins Levick's In House Warrior to discuss clinical trials during the COVID-19 pandemic, FDA regulation and healthcare privacy."
    United StatesFood, Drugs, Healthcare, Life Sciences
    Arnold & Porter
    Arnold & Porter
  • Article

    Incoming GOP Senate Will Likely Press FDA To Ease Up On Regulation

    As a result of this week's midterm elections, the incoming Republican majority will likely try to challenge FDA on several fronts, seeking to ease regulatory burdens for drug and device manufacturers.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Jones Day
    Jones Day
  • Article

    Individualized Quality Control Plan For CLIA Laboratory Non-Waived Testing (May 19)

    CMS is hosting a provider call on May 19, 2014 regarding the Clinical Laboratory Improvement Amendments Individualized Quality Control Plan.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Reed Smith
    Reed Smith
  • Video

    Innovations In Consumer Health (Video)

    Raqiyyah Pippins talks about the exciting new trends in consumer health product regulation.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Arnold & Porter
    Arnold & Porter
  • Article

    Investor Interest In Health IT Firms Continues

    Chicago partners Geoffrey Cockrell and Amber McGraw Walsh co-authored a Law360 article titled "Investor Interest In Health IT Firms Continues."
    United StatesFood, Drugs, Healthcare, Life Sciences
    McGuireWoods LLP
    McGuireWoods LLP
  • Article

    January Issue Of Bio Pharma Beat Now Available

    Our monthly newsletter reports on the patent law developments in biotech, biologics and pharmaceutical cases, legislation and federal agency actions.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Squire Patton Boggs LLP
    Squire Patton Boggs LLP
  • Article

    Law & Toxicology

    Partner Tony Hopp recently co-authored a chapter, "Law & Toxicology," which appeared in the fourth edition of Encyclopedia of Toxicology. The chapter describes the interplay between toxicology...
    United StatesFood, Drugs, Healthcare, Life Sciences
    Steptoe LLP
    Steptoe LLP
  • Article

    Life Sciences at the PTAB

    Later this month, the Boston Bar Association and the Boston Patent Law Association will jointly host a panel discussion on the recent rise of life science litigation at the U.S. Patent Office's Patent Trial and Appeal Board ("PTAB").
    United StatesFood, Drugs, Healthcare, Life Sciences
    Proskauer Rose LLP
    Proskauer Rose LLP
  • Video

    Life Sciences IP (Video)

    Intellectual Property Practice Leader Anthony Insogna discusses how Jones Day can develop a strong IP plan for your company, ...
    United StatesFood, Drugs, Healthcare, Life Sciences
    Jones Day
    Jones Day
  • Article

    Long-Awaited HIPAA And HITECH Final Rule Released

    A final omnibus rule which makes changes to the Health Insurance Portability and Accountability Act regulations related to privacy and security, has been released by the Department of Health and Human Services.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Drinker Biddle & Reath LLP
    Drinker Biddle & Reath LLP
  • Article

    Medical Device Company Settles FCPA Investigation With DOJ And SEC

    On Feb. 6, 2012, UK-based medical device company Smith & Nephew settled a civil and criminal investigation of alleged violations of the Foreign Corrupt Practices Act (FCPA) by agreeing to pay a total of $22.6 million and committing to certain measures designed to reduce the possibility of repeat conduct.
    United StatesFood, Drugs, Healthcare, Life Sciences
    McGuireWoods LLP
    McGuireWoods LLP
  • Article

    Medicare's Latest MedTech Proposal: Transitional Coverage For Emerging Technologies

    In June, the Centers for Medicare & Medicaid Services released is much-anticipated proposal to offer "transitional coverage for emerging technologies."
    United StatesFood, Drugs, Healthcare, Life Sciences
    Goodwin Procter LLP
    Goodwin Procter LLP
  • Article

    Nano Prominent In New OSTP Report For Advanced Manufacturing

    The OSTP has recently posted a report on advanced manufacturing, which identifies eleven "cross-cutting" technologies.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Foley & Lardner LLP
    Foley & Lardner LLP
  • Showing 141–160 of 7150 results

    PreviousNext
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics